Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStopping Mounjaro is a decision that should be made with your prescriber, not unilaterally. You can stop Mounjaro at any time — it is not physically addictive — but how you stop, and when, can significantly affect what happens next to your appetite, your weight, and your long-term results. This is a prescription-only medicine, and any changes to your treatment should be reviewed by a clinician before you act.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide does not cause physical dependence, so there is no clinical requirement to step the dose down gradually before stopping. Unlike some medications (antidepressants, for example) you are not at risk of a withdrawal syndrome if you stop Mounjaro from one week to the next. That said, your prescriber may still recommend a planned reduction rather than an immediate stop, particularly if you are on a higher dose, because the abruptness of stopping can make the return of appetite feel more jarring.
A question our prescribers hear most weeks is whether stopping mid-pen wastes medication or causes any harm. The short answer is no: tirzepatide leaves your system gradually over several weeks regardless of the dose you were taking, and there is no clinical risk from finishing a pen or simply not injecting the next scheduled dose.
The NHS tirzepatide information page advises patients not to stop treatment without talking to their doctor or pharmacist first. That is sensible guidance, not because stopping is dangerous, but because stopping without a plan rarely serves you well.
Mounjaro works by activating GIP and GLP-1 receptors that regulate appetite signals and slow gastric emptying. While it is active, many people find that hunger feels quieter, portion sizes naturally reduce, and food noise (the mental preoccupation with eating) diminishes. Stop the injections and those effects fade as tirzepatide clears your system over two to four weeks.
What follows for most people is a gradual return of pre-treatment hunger levels. Some people experience this as a sudden increase in appetite; others notice it slowly over a month or two. Weight regain is common after stopping GLP-1 and GIP medicines, and the evidence from obesity medicine broadly suggests that obesity is a chronic condition that often requires ongoing management rather than a fixed-duration course. That is not meant to be discouraging, plenty of people stop treatment after building robust habits and maintain their results well. But it is worth being honest about the biology.
If you are concerned about keeping weight off after stopping, the guide to managing weight after Mounjaro covers the practical strategies worth having in place before you stop, not after.
People stop Mounjaro for several legitimate reasons, and the right approach differs by situation. Side effects are a common driver, particularly early in treatment. Nausea, bloating, and digestive discomfort are most likely to peak around dose increases and typically settle within a couple of weeks. If side effects are the issue, it is worth asking your prescriber whether staying at your current dose for longer (rather than stopping) might resolve things. Information on managing bloating on Mounjaro may also be useful in the shorter term.
Cost is another reason people stop. Mounjaro is a private prescription medicine and the expense is real. The Mounjaro pricing page sets out what transparent, all-inclusive private treatment looks like, which may help you plan ahead rather than stop abruptly because an unexpected bill arrives. Planned pauses are easier to manage than emergency stops.
Pregnancy, breastfeeding, or trying to conceive are reasons to stop immediately: Mounjaro is not recommended in any of these situations. Notify your prescriber promptly so they can advise on timing and contraception appropriately.
Surgery is another situation that requires early action. Tell your anaesthetist and surgical team that you are taking tirzepatide well before any planned procedure, and follow your prescriber's guidance on stopping in advance. The NHS England guidance on weight-management injections covers perioperative considerations in detail.
When you decide to stop Mounjaro, the most useful conversation with your prescriber covers four things: why you are stopping, whether the reason has a fix short of stopping, what your weight-management plan looks like post-treatment, and whether a pause is more appropriate than a permanent stop.
Some people stop because they have reached their goal weight and feel ready to continue without the medicine. Others stop temporarily (during a pregnancy attempt, before surgery, or because of a supply interruption) and plan to restart. Restarting after a break typically means returning to the starting dose rather than picking up where you left off, both for tolerability and for prescriber assessment. The detail on when stopping Mounjaro makes clinical sense goes into the timing questions in more depth.
The wider question of how to approach stopping Mounjaro practically (including what lifestyle elements to have in place first) is worth reading alongside this page. And if you are curious how stopping applies across the tirzepatide product more broadly, the tirzepatide stopping guide covers the same ground from a slightly different angle.
If you have not yet started treatment and are weighing up your options, our prescribers at weight-loss treatments are available for a free same-day consultation. Every decision, including when and how to stop, is reviewed by a real clinician, not software.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.